XML 44 R43.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)

Loss before income tax expense (benefit) was comprised of the following for the periods indicated (in thousands):
 
Year Ended December 31,
 
2019
 
2018
 
2017
 
 
 
 
 
 
United States
$
(225,653
)
 
$
(85,342
)
 
$
(167,908
)
Foreign
14,118

 
(8,341
)
 
81,369

Loss before income tax expense (benefit)
$
(211,535
)
 
$
(93,683
)
 
$
(86,539
)


Income taxes have been provided for based upon the tax laws and rates in the countries in which operations are conducted and income is earned. Components of income tax expense (benefit) consist of the following for the periods indicated (in thousands):
 
Year Ended December 31,
 
2019
 
2018
 
2017
Current
 
 
 
 
 
U.S. federal
$

 
$

 
$

U.S. state and local
209

 
7

 
(15
)
Foreign
21,975

 
11,677

 
10,516

Total current
22,184

 
11,684

 
10,501

 
 
 
 
 
 
Deferred
 
 
 
 
 
U.S. federal
444

 

 
56,621

U.S. state and local

 

 
2,420

Foreign
1,166

 
(14,634
)
 
3,376

Total deferred
1,610

 
(14,634
)
 
62,417

Total income tax expense (benefit)
$
23,794

 
$
(2,950
)
 
$
72,918


Schedule of Foreign Taxes Incurred
Foreign taxes were incurred in the following regions for the periods indicated (in thousands):
 
Year Ended December 31,
 
2019
 
2018
 
2017
 
 
 
 
 
 
Latin America
$
8,636

 
$
1,261

 
$
5,469

West Africa
4,688

 
2,692

 
3,243

Middle East
5,579

 
2,249

 
1,633

Europe
1,096

 
461

 
1,348

Asia Pacific
1,525

 
922

 
1,388

Other
1,617

 
(10,542
)
 
812

Total foreign income tax expense (benefit)
$
23,141

 
$
(2,957
)
 
$
13,893



Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the differences between the income tax provision computed at the 21% U.S. statutory rate in effect at December 31, 2019 and the reported provision for income taxes for the periods indicated is as follows (in thousands):
 
Year Ended December 31,
 
2019
 
2018
 
2017
 
 
 
 
 
 
Income tax expense (benefit) at statutory rate
$
(44,422
)
 
$
(19,673
)
 
$
(30,289
)
Branch profits tax
(12,129
)
 
(4,267
)
 
(4,871
)
State taxes, net of federal benefit
154

 
(27
)
 
2,405

Restricted stock units tax shortfall
405

 
1,025

 
1,651

Taxes on foreign earnings at less than the U.S. statutory rate
14,427

 
13,095

 
(22,464
)
Effect of tax rate change

 
(2,929
)
 
23,843

Effect of moving activity to higher tax rate jurisdiction

 
(14,620
)
 

Management fee charged to international operations
3,455

 
1,515

 
1,213

Tax effect of TRA derecognition

 

 
46,874

Establishment of valuation allowances
37,802

 
22,892

 
51,911

Goodwill impairment
25,677

 

 

Return-to-provision adjustments
(524
)
 
(521
)
 
3,551

Foreign tax credit
(5,707
)
 

 

Other
4,656

 
560

 
(906
)
Total income tax expense (benefit)
$
23,794

 
$
(2,950
)
 
$
72,918


Schedule of Deferred Tax Assets and Liabilities

Significant components of deferred tax assets and liabilities are as follows (in thousands):
 
December 31,
 
2019
 
2018
Deferred tax assets
 
 
 
Foreign net operating loss
$
17,121

 
$
13,290

U.S. net operating loss
104,105

 
76,349

Research and development credit
1,016

 
609

Foreign tax credit carryover
422

 

Intangibles
9,365

 
5,933

Inventory
2,280

 
2,350

Property and equipment
16,161

 
14,621

Investment in partnership
24,372

 
23,931

Other
1,442

 
773

Valuation allowance
(130,010
)
 
(84,972
)
Total deferred tax assets
46,274

 
52,884

 
 
 
 
Deferred tax liabilities
 
 
 
Investment in partnership
(23,728
)
 
(27,352
)
Property and equipment
(1,253
)
 
(3,652
)
Goodwill
(7,297
)
 
(7,259
)
Other
(329
)
 
(221
)
Total deferred liabilities
(32,607
)
 
(38,484
)
 
 
 
 
Net deferred tax assets (liabilities)
$
13,667

 
$
14,400


Summary of Operating Loss Carryforwards The ultimate utilization of the NOLs and research and development credits depend on the ability to generate sufficient taxable income in the appropriate tax jurisdiction. These tax attributes expire as follows (in thousands):
Year of Expiration
 
U.S. NOLs
 
Foreign NOLs
 
R&D Credits
 
 
 
 
 
 
 
2020 - 2024
 
$

 
$
11,598

 
$

2025 - 2029
 

 
8,084

 

2030 - 2038
 
196,550

 

 
1,016

Does not expire
 
174,623

 
52,746

 

 
 
$
371,173

 
$
72,428

 
$
1,016


Summary of Tax Credit Carryforwards The ultimate utilization of the NOLs and research and development credits depend on the ability to generate sufficient taxable income in the appropriate tax jurisdiction. These tax attributes expire as follows (in thousands):
Year of Expiration
 
U.S. NOLs
 
Foreign NOLs
 
R&D Credits
 
 
 
 
 
 
 
2020 - 2024
 
$

 
$
11,598

 
$

2025 - 2029
 

 
8,084

 

2030 - 2038
 
196,550

 

 
1,016

Does not expire
 
174,623

 
52,746

 

 
 
$
371,173

 
$
72,428

 
$
1,016